Safety and efficacy of flumatinib as later-line therapy in patients with chronic myeloid leukemia.
Yang Y, Liu Y, Sun H, Meng L, Lin H, Chen C, Hu J, Shen X, Duan M, Zhang Y, Abulaiti D, Wang J, Zhu H, Hua L, Leng Q, Zhang C, Sun L, Li W, Zhu H, Liu B, Wang J.
Yang Y, et al. Among authors: leng q.
Haematologica. 2024 Jun 27. doi: 10.3324/haematol.2023.284892. Online ahead of print.
Haematologica. 2024.
PMID: 38934064
Free article.